KRAS and colorectal carcinoma: In conclusion, we studied mutations in the RAS-RAF and PI3K-PTEN-AKT pathways, especially the frequencies and distributions of so-called rare mutations, including KRAS exons 3 and 4, and NRAS exons 2 and 3 in 353 Chinese CRC patients.